Literature DB >> 28889970

Genomic signature analysis of the recently emerged highly pathogenic A(H5N8) avian influenza virus: implying an evolutionary trend for bird-to-human transmission.

Wei Xu1, Yanyan Dai1, Chen Hua1, Qian Wang1, Peng Zou1, Qiwen Deng2, Shibo Jiang3, Lu Lu4.   

Abstract

In early 2014, a novel subclade (2.3.4.4) of the highly pathogenic avian influenza (HPAI) A(H5N8) virus caused the first outbreak in domestic ducks and migratory birds in South Korea. Since then, it has spread to 44 countries and regions. To date, no human infections with A(H5N8) virus have been reported, but the possibility cannot be excluded. By analyzing the genomic signatures of A(H5N8) strains, we found that among the 47 species-associated signature positions, three positions exhibited human-like signatures (HLS), including PA-404S, PB2-613I and PB2-702R and that mutation trend of host signatures of avian A(H5N8) is different before and after 2014. About 82% of A(H5N8) isolates collected after January of 2014 carried the 3 HLS (PA-404S/PB2-613I/PB2-702R) in combination, while none of isolates collected before 2014 had this combination. Furthermore, the HA protein had S137A and S227R substitutions in the receptor-binding site and A160T in the glycosylation site, potentially increasing viral ability to bind human-type receptors. Based on these findings, the newly emerged HPAI A(H5N8) isolates show an evolutionary trend toward gaining more HLS and, along with it, the potential for bird-to-human transmissibility. Therefore, more extensive surveillance of this rapidly spreading HPAI A(H5N8) and preparedness against its potential pandemic are urgently needed.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  A(H5N8); Highly pathogenic avian influenza virus; Influenza; Influenza A virus

Mesh:

Year:  2017        PMID: 28889970     DOI: 10.1016/j.micinf.2017.08.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  8 in total

1.  Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020-21.

Authors:  Jacqueline King; Timm Harder; Anja Globig; Lina Stacker; Anne Günther; Christian Grund; Martin Beer; Anne Pohlmann
Journal:  Virus Evol       Date:  2022-04-13

Review 2.  Molecular Markers for Interspecies Transmission of Avian Influenza Viruses in Mammalian Hosts.

Authors:  Khristine Kaith S Lloren; Taehyung Lee; Jin Jung Kwon; Min-Suk Song
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

3.  Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza Vaccination.

Authors:  Peiyu Li; Ji Wang; Miao Cao; Qiwen Deng; Shibo Jiang; Mei X Wu; Lu Lu
Journal:  Front Microbiol       Date:  2018-10-30       Impact factor: 5.640

4.  Serological Evidence of Backyard Pig Exposure to Highly Pathogenic Avian Influenza H5N8 Virus during 2016-2017 Epizootic in France.

Authors:  Séverine Hervé; Audrey Schmitz; François-Xavier Briand; Stéphane Gorin; Stéphane Quéguiner; Éric Niqueux; Frédéric Paboeuf; Axelle Scoizec; Sophie Le Bouquin-Leneveu; Nicolas Eterradossi; Gaëlle Simon
Journal:  Pathogens       Date:  2021-05-18

5.  Highly pathogenic avian H5N8 influenza viruses: should we be concerned?

Authors:  M D Tate
Journal:  Virulence       Date:  2017-11-27       Impact factor: 5.882

6.  The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses.

Authors:  Wei Xu; Shuai Xia; Jing Pu; Qian Wang; Peiyu Li; Lu Lu; Shibo Jiang
Journal:  Front Microbiol       Date:  2018-11-06       Impact factor: 5.640

7.  Avian influenza overview September - November 2017.

Authors:  Ian Brown; Thijs Kuiken; Paolo Mulatti; Krzysztof Smietanka; Christoph Staubach; David Stroud; Ole Roland Therkildsen; Preben Willeberg; Francesca Baldinelli; Frank Verdonck; Cornelia Adlhoch
Journal:  EFSA J       Date:  2017-12-22

8.  Avian influenza overview November 2017 - February 2018.

Authors:  Cornelia Adlhoch; Adam Brouwer; Thijs Kuiken; Paolo Mulatti; Krzysztof Smietanka; Christoph Staubach; Preben Willeberg; Federica Barrucci; Frank Verdonck; Laura Amato; Francesca Baldinelli
Journal:  EFSA J       Date:  2018-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.